Can a multidisciplinary clinic improve life for MSA patients?
NCT ID NCT03811808
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 200 people with Multiple System Atrophy (MSA) to see if receiving care from a team of specialists every four months improves their quality of life and eases the burden on their caregivers. Participants and their doctors will complete questionnaires about daily activities and disease progression. The goal is to understand how coordinated care can help manage this rare neurological condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could show that a team-based care approach improves quality of life for people with MSA and reduces caregiver burden.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test a new drug or therapy, so it cannot lead to a cure or direct symptom relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Start date
-
Mar 2016
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults 18 years or older with diagnosis of possible or probable MSA
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Subject must be a patient in the UT Southwestern MSA clinic and be able to attend the multidisciplinary clinic every 4 months * Patients with possible or probable MSA based on established criteria * Subjects must be 18 years or older Exclusion Criteria: * Patients that are unable to give consent * Minor patients (younger than age 18) * Non-English speaking patients * Subjects that are diagnosed with dementia
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Multiple system atrophy (MSA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
UT Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New PET tracer aims to spot Parkinson's in the brain
- New brain scan tracer could spot Parkinson's and related disorder
- New hope for rare brain disorder: drug trial targets MSA
- Hope for MSA: new drug aims to slow rare brain disease
- New PET tracer aims to spot Parkinson's protein in the brain
- New protein therapy hopes to repair brain damage in rare disease